Middle East & Africa Embolotherapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Embolic Agent and Support Device), Disease Indication (Cancer, Peripheral Vascular Disease, Neurological Disease, Urological and Nephrological

Middle East & Africa Embolotherapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Embolic Agent and Support Device), Disease Indication (Cancer, Peripheral Vascular Disease, Neurological Disease, Urological and Nephrological Disorder, Gastrointestinal Disorder, and Other), Procedure [Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT), and Transarterial Chemoembolization (TACE)], and End User (Hospital & Clinic, Ambulatory Surgery Center, and Other End User)

The embolotherapy market in the Middle East & Africa is expected to grow from US$ 183.66 million in 2022 to US$ 261.89 million by 2028. It is estimated to grow at a CAGR of 6.1% from 2022 to 2028.

Widening Applications of Embolotherapy to Bolster Embolotherapy Market in Middle East & Africa during 2022–2028

Embolization is performed within the artery (endovascular) through a steerable catheter inserted into the bloodstream and guided to the brain. Further, post-traumatic bleeding embolization is performed to stop bleeding caused by traumatic injuries. The method uses materials to block the affected vessel and stops blood flow. According to a Netcare hospital article, traumatic brain injury (TBI) is one of the leading causes of disability in South Africa, and 89,000 new cases of TBI are reported every year in the country. Thus, the rising adoption of embolization in various applications further increases the demand for embolization agents and supportive devices. Therefore, the growing applications of embolotherapy devices are expected to boost the growth of the embolotherapy market. Also, the increasing implementation of embolotherapy in the treatment of endovascular disease, traumatic injuries, cerebrovascular malformation, venous malformation, arteriovenous malformation, and pediatric vascular conditions is expected to offer lucrative opportunities for the market growth in the coming years.

Market Overview



The embolotherapy market in the Middle East & Africa is segmented into Saudi Arabia, the UAE, South Africa, and the rest of Middle East & Africa. In the current market scenario, Middle East is experiencing an increasing incidence of chronic diseases, such as strokes, neurological disorders, and cancer; rise in geriatric population; and adaption of unhealthy lifestyles. Moreover, acceptance and installations of modern technologies are projected to drive the market growth in this region. The high incidence of chronic diseases, the rise in aging population, and improvements in the treatment procedures of various chronic conditions are among the key factors propelling the market growth in Saudi Arabia. CVD is the most significant cause of premature death in Saudi Arabia. It accounts for ~37% of deaths in the country. As per a study, the prevalence rates of chronic diseases in Saudi Arabia has surged in the past few years, accounting for ~60 and ~73% of the total premature deaths in 2016 and 2020, respectively. Hypertension is the most common chronic disease, with prevalence rates of 26%. In addition, in the country, the incidence of uterine fibroids (UFs) at reproductive age is 21.2% in 2018 and poses a major burden on fertile Saudi women. Uterine fibroid embolization, a safe, effective, and minimally invasive procedure is becoming an important gynecological and interventional radiological procedure to treat UF. King Fahd Hospital – Al-Hofouf has successfully treated several benign uterine fibroids cases using uterine fibroid embolization, as per Al-Ahsa Health Affairs. This treatment uses a form of real-time x-ray to guide delivery of embolic agents to the uterus and fibroids. The agents block the arteries that provide blood to the fibroids and cause them to shrink and clear up.

Middle East & Africa Embolotherapy Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Embolotherapy Market Segmentation

The Middle East & Africa embolotherapy market is segmented into product, disease indication, procedure, end user, and country.

Based on procedure, the market is segmented into embolic agents and support devices. The embolic agents segment registered the largest market share in 2022. Based on disease indication, the market is categorized into cancer, neurological diseases, urological and nephrological disorders, peripheral vascular diseases, gastrointestinal disorders, and others. The cancer segment held the largest market share in 2022. Based on procedure, the Middle East & Africa embolotherapy market is segmented into transcatheter arterial embolization (TAE), transcatheter arterial radioembolization/selective internal radiation therapy, and transarterial chemoembolization (TACE). The transcatheter arterial embolization (TAE) segment held the largest market share in 2022. Based on end user, the Middle East & Africa embolotherapy market is segmented into hospitals and clinics, ambulatory surgical centers, and other end users. The hospitals and clinics segment held the largest market share in 2022. Based on country, the market is segmented into Saudi Arabia, South Africa, the UAE, and the rest of the MEA. China dominated the market share in 2022. Abbott Laboratories; Boston Scientific Corporation; Cook Medical LLC; Johnson & Johnson; Medtronic; Acandis GmbH; Balt USA LLC; Stryker Corporation; Guerbet LLC; and Terumo Corporation are the leading companies operating in the embolotherapy market in the region.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa embolotherapy market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa embolotherapy market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the embolotherapy market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution